Author: Lynne Taylor

Members of Parliament have criticised the Scottish government for failing to ensure that its military veterans receive the same fast-track National Health Service treatment as is provided to retired service personnel in England.

As Thailand’s new government considers whether to continue with the country’s controversial compulsory licensing policy, which has enabled it to override the patents on a number of branded drugs, an international mission has confirmed that its use of the mechanism has been legal.

Failure to act by the US Food and Drug Administration has increased the risk that criminals are operating in, and undermining, the drug regulatory process, Congress has been warned.

As US consumers go to the polls “with access to affordable health care at the top of their minds,” generics – and biogenerics – “are the solution to reducing health care costs while increasing access to quality care,” according to Kathleen Jaeger, chief executive of the US Generic Pharmaceutical Association (GPhA), speaking as its annual conference got underway this week in Florida.

South Africa is to prosecute three pharmaceutical suppliers, after a three-year investigation by the Competition Commission found they had colluded to fix prices and split the market when bidding for government tenders to supply public hospitals.